Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04632303 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Early Palliative Care for Patients With Advanced Pancreatic Cancer.

Study acronym: EarlyCarePan
StatusActive, Not Recruiting
PhaseNot applicable
Started2021-06-23
View on ClinicalTrials.gov ↗
Pancreatic adenocarcinoma is one of the deadliest cancers. Patients with pancreatic cancer experience marked physical suffering, psychological distress and resource-demanding care at the end-of-life. Therefore, an urgent need exists to evaluate the early specialized palliative care model in a comparative study and across multiple care settings to define quality of life and survival benefits in patients with pancreatic cancer.

Amendment record

Amended 7 times since 2020-11-13; most recent filed 2025-09-08. Every amendment is listed below.

Dates here are the day the sponsor filed the amendment, not the day ClinicalTrials.gov published it. Version history last read from ClinicalTrials.gov on 2026-08-30.

2025-09-08
Amendment Study Identification, Study Status v7
2024-11-24
Amendment Study Status v6
2024-09-30
Amendment Recruiting→Active, Not Recruiting Study Identification, Study Status, Oversight, Contacts/Locations v5
2023-02-28
Amendment Study Status v4
2022-08-01
Amendment Study Status v3
2021-07-22
Amendment Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v2
2021-02-09
Amendment Study Status, Sponsor/Collaborators v1
2020-11-13
Original filing
Trial Details
NCT Number NCT04632303
Lead Sponsor Inna Chen, MD
Collaborators: Bispebjerg Hospital, Rigshospitalet, Denmark, Hvidovre University Hospital, Odense University Hospital, Aalborg University Hospital, Aarhus University Hospital, Vejle Hospital, Zealand University Hospital, Hillerod Hospital, Denmark, Herning Hospital
Conditions Pancreatic Cancer
Enrollment 250 participants
Start Date 2021-06-23
Primary Completion 2024-11-07 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2025-09-12